Monoclonal Antibodies Software
1 software items found
-
by Certarabased in USA
Biological medicines (“biologics” or “large molecule drugs”) now account for 30% of new drug approvals and up to 50% of the pharmaceutical industry’s pipeline. Biologics differ from small molecules because they are much larger, have slower absorption rates, confined distribution, and different elimination. They are designed for a specific target, typically found on ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you